King Faisal Specialist Hospital & Research Center
Riyadh, Saudi Arabia
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
Multiple Myeloma
Janssen Research & Development, LLC795 enrolled242 locationsNCT06208150
Recruiting
Phase 3
Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients
Acute Myeloid Leukemia (AML) in RemissionAcute Lymphoblastic Leukemia (ALL) in Complete Remission
King Faisal Specialist Hospital & Research Center264 enrolled1 locationNCT04314219